Business Segment and Geographical Information (Tables)

12 Months Ended

Dec. 31, 2024

Business Segment Information

2024


(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Revenues
Revenues from external customers	$	8,160	$	7,267	$	4,449	$	23,002	$	42,879
Intersegment revenues	1,471		196		63		155		1,885
	9,631		7,463		4,512		23,157		44,764
Elimination of intersegment revenues									(1,885)
Consolidated revenues									$	42,879
Segment Income
Cost of revenues	3,559		3,535		2,605		18,074
Selling, general, and administrative expenses	1,799		1,251		741		2,378
Research and development expenses	551		554		176		73
Other segment items	219		167		(168)		(459)
Segment income	3,503		1,955		1,159		3,090		9,707
Unallocated amounts
Cost of revenues adjustments									(47)
Selling, general and administrative expenses adjustments									8
Restructuring and other costs									(379)
Amortization of acquisition-related intangible assets									(1,952)
Interest income									1,078
Interest expense									(1,390)
Other income/(expense)									12
Consolidated income before income taxes									$	7,037


(In millions)	Unallocated amounts		Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Consolidated
Segment assets	$	84,031	$	2,982	$	2,944	$	1,218	$	6,145	$	97,321
Purchases of property, plant and equipment	85		123		95		125		971		1,400
Depreciation of property, plant and equipment	—		230		103		104		721		1,156

2023


(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Revenues
Revenues from external customers	$	8,545	$	7,101	$	4,324	$	22,888	$	42,857
Intersegment revenues	1,432		163		82		154		1,829
	9,977		7,263		4,405		23,041		44,686
Elimination of intersegment revenues									(1,829)
Consolidated revenues									$	42,857
Segment Income
Cost of revenues	4,072		3,468		2,592		18,033
Selling, general, and administrative expenses	1,791		1,252		724		2,304
Research and development expenses	558		528		156		68
Other segment items	136		107		(191)		(722)
Segment income	3,420		1,908		1,124		3,358		9,810
Unallocated amounts
Cost of revenues adjustments									(95)
Selling, general and administrative expenses adjustments									(59)
Restructuring and other costs									(459)
Amortization of acquisition-related intangible assets									(2,338)
Interest income									879
Interest expense									(1,375)
Other income/(expense)									(65)
Consolidated income before income taxes									$	6,298


(In millions)	Unallocated amounts		Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Consolidated
Segment assets	$	85,314	$	3,186	$	2,726	$	1,150	$	6,350	$	98,726
Purchases of property, plant and equipment	80		178		87		121		1,013		1,479
Depreciation of property, plant and equipment	—		220		93		86		669		1,068

2022


(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Revenues
Revenues from external customers	$	11,565	$	6,441	$	4,604	$	22,304	$	44,915
Intersegment revenues	1,967		182		158		207		2,515
	13,532		6,624		4,763		22,511		47,430
Elimination of intersegment revenues									(2,515)
Consolidated revenues									$	44,915
Segment Income
Cost of revenues	4,973		3,194		3,095		17,830
Selling, general, and administrative expenses	2,027		1,235		605		2,347
Research and development expenses	680		508		147		85
Other segment items	270		180		(108)		(623)
Segment income	5,582		1,507		1,024		2,872		10,985
Unallocated amounts
Cost of revenues adjustments									(46)
Selling, general and administrative expenses adjustments									(37)
Restructuring and other costs									(114)
Amortization of acquisition-related intangible assets									(2,395)
Interest income									272
Interest expense									(726)
Other income/(expense)									(104)
Consolidated income before income taxes									$	7,835


(In millions)	Unallocated amounts		Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Consolidated
Segment assets	$	83,340	$	3,845	$	2,465	$	1,076	$	6,428	$	97,154
Purchases of property, plant and equipment	98		490		140		112		1,403		2,243
Depreciation of property, plant and equipment	—		214		83		75		614		986

Geographical Information


(In millions)	2024		2023		2022
Revenues
United States	$	21,755	$	22,013	$	23,820

Other	21,124		20,844		21,095
Consolidated revenues	$	42,879	$	42,857	$	44,915

Long-lived Assets
United States	$	6,245	$	6,352	$	6,308
Other	4,550		4,652		4,565
Consolidated long-lived assets	$	10,795	$	11,004	$	10,873